$ARM
π Fundamentals & Growth Outlook
π¦ ARM (ARM) β A Leading Semiconductor IP Player with Robust Growth Potential
Continued high gross margin revenue from licensing and royalties; sustained growth in licensing demand for AI/data center and mobile chips.
Playing a key role in AI accelerators and Next-Gen SoCs, with significant growth in licensee customers.
Solid fundamentals, with revenue and gross margins remaining high (exceeding expected growth). Earnings season guidance and licensing revenue growth indicators.
Confirmation of a turning point in the semiconductor industry cycle is conducive to price increases.
π Valuation (DCF + Relative)
Method: Primarily relative valuation, DCF used to confirm the upper limit of valuation.
Forward P/S: 18β22x (AI IP scarcity premium)
Long-term FCF CAGR: ~18β22%
DCF Implied Fair Value Range: $100β$125
π Current Price β $114
β‘οΈ Valuation Conclusion: Reasonably expensive, but not a bubble.
π Technical Analysis & Trading
Strong Support: 105β108
Secondary Support: 98β100 (Excellent add-on zone)
Resistance Levels: 125 / 138
π― Strategy
Buy: In batches at 105β110
Add to position: Around 100
Stop-loss (Mid-term): Below 95 weekly close
Target: 130β145
π Positioning: Long-term AI semiconductor "bond-grade" core assets
#StockMarket
AI application software stocks fell across the board, with ServiceNow down more than 14% after its earnings release, Atlassian down more than 10%, Salesforce, Adobe, and Figma down more than 8%, Workday down more than 7%, Snowflake down more than 6%, Applovin down more than 5%,
Bitcoin Holds Near $70K Before Major Options Expiry
News: Bitcoin trades near $70Kβ$71K as $18.6B options expiry approaches, increasing volatility expectations.
Trump posted a warning that if Iran does not comply, he will destroy its power plants within 48 hours, mentioning the Strait of Hormuz. BTC quickly broke through the $69,200 support level, and ETH followed suit, considered the biggest catalyst of the day.
$PSFE
Paysafe is a global payment technology and financial infrastructure service provider, offering services such as digital wallets, card payments, and transaction clearing. The company focuses on B2B2C payment solutions and has strong competitiveness in the digital commerce and fintech sectors.
Technical Analysis and Price Structure
Current Price: $6.75
Support Levels: $6.0β$7.0
Resistance Levels: $8.5β$9.0
Buy Range: $6.3β$7.5
Target Price
First Target Price: $9.0β$10.0
Second Target Price: $12+
Paysafe's technical indicators show short-term momentum is neutral to slightly volatile, but the support level is clear. Fundamentally, it holds a leading position in fintech payment infrastructure, and its growth logic remains intact.
π If this interests you, please follow, like, and comment βstocksββI'll DM you.
#PSFE
#StockMarket
#StockAnalysis
#TechnicalAnalysis
#FundamentalAnalysis
$DEO +4.39%
The stock market closed today, and my prediction was completely correct. Many people want to know my stock selection strategy, which I will share with everyone. If you want to understand my insights, please follow me and like this post. Simply reply with "π" in the comments section, and I will reply to you privately.
#DEO #StockMarket #StockAnalysis #TechnicalAnalysis #FundamentalAnalysis
$DEO
Diageo is a leading global spirits and beverage company, owning well-known brands such as Johnnie Walker, Guinness, and Smirnoff, with operations spanning global consumer markets. Its strong consumer demand and brand power are its long-term support.
Technical Analysis and Price Structure
Current Price: $93.11
Support Levels: $83.5β$84.5
Resistance Levels: $97.5β$98.5
Buy Range: $91.5β$94.5
Target Price
First Target Price: $105-$110
Second Target Price: $115+
$DEO is a relatively stable consumer goods stock with a strong brand moat and dividend-paying ability, suitable for long-term, stable investment. Risks include the impact of economic cycles on high-priced consumer spending.
π If this interests you, please follow, like, and comment βstocksββI'll DM you.
#DEO
#StockMarket
#StockAnalysis
#TechnicalAnalysis
#FundamentalAnalysis
$DEO
Diageo is a leading global spirits and beverage company, owning well-known brands such as Johnnie Walker, Guinness, and Smirnoff, with operations spanning global consumer markets. Its strong consumer demand and brand power are its long-term support.
Technical Analysis and Price Structure
Current Price: $93.11
Support Levels: $83.5β$84.5
Resistance Levels: $97.5β$98.5
Buy Range: $91.5β$94.5
Target Price
First Target Price: $105-$110
Second Target Price: $115+
$DEO is a relatively stable consumer goods stock with a strong brand moat and dividend-paying ability, suitable for long-term, stable investment. Risks include the impact of economic cycles on high-priced consumer spending.
π If this interests you, please follow, like, and comment βstocksββI'll DM you.
#DEO
#StockMarket
#StockAnalysis
#TechnicalAnalysis
#FundamentalAnalysis
$FENC +1.15%
The trend is upward today, and my judgment was absolutely correct. Many people want to know my stock selection strategy, which I will share with everyone. If you want to understand my insights, please follow me and like this post. Simply reply with "π" in the comments section, and I will reply to you privately.
$FENC
Fennec Pharmaceuticals is a U.S. commercial-stage biopharmaceutical company whose primary product is PEDMARK, a treatment for chemotherapy-induced hearing loss, with clinical and market potential in the oncology patient care market
Technical Analysis and Price Structure
Current Price: $7.83
Support Levels: $6.5β$7.0
Resistance Levels: $8.5β$9
Buy Range: $7.0β$8.0
Target Price
First Target Price: $10β$11
Second Target Price: $13+
$FENC has potential growth drivers from drug market expansion and sales growth, but its fundamental profitability is still unstable and volatile. Attention should be paid to the progress of clinical adoption and the pace of revenue growth
#StockMarket
#StockAnalysis
#TechnicalAnalysis
#FundamentalAnalysis
$FENC
Fennec Pharmaceuticals is a U.S. commercial-stage biopharmaceutical company whose primary product is PEDMARK, a treatment for chemotherapy-induced hearing loss, with clinical and market potential in the oncology patient care market
Technical Analysis and Price Structure
Current Price: $7.83
Support Levels: $6.5β$7.0
Resistance Levels: $8.5β$9
Buy Range: $7.0β$8.0
Target Price
First Target Price: $10β$11
Second Target Price: $13+
$FENC has potential growth drivers from drug market expansion and sales growth, but its fundamental profitability is still unstable and volatile. Attention should be paid to the progress of clinical adoption and the pace of revenue growth
#StockMarket
#StockAnalysis
#TechnicalAnalysis
#FundamentalAnalysis
$VOR
Virgin Orbit (VOR) US stock. The company primarily engages in small satellite launch services and is one of the companies in the commercial space sector.
Technical Analysis and Price Structure
Current Price: $13.99
Support Levels: $10-$11
Resistance Levels: $17.5-$18.5
Buying Range: $13.5-$15
Target Prices
Primary Target: $18β20
Secondary Target: $25+
As a commercial space sector stock, $VOR remains in its early growth phase with pronounced volatility and high risk. Its earnings and revenue remain modest, necessitating close monitoring of launch progress and contract execution.
π Interested? Follow, like, and comment βstocksβ belowβI'll DM you.
#Trading
#StockMarket
#SNDK
@HvBCapital@10009nyny@grok If there are any errors in the content please point them out Focusing on other things while ignoring the argument itself won't truly move the discussion forward If you disagree with the content of the article I'd be happy to discuss it with you
$AMTX
Aemetis is a new energy and renewable fuels company specializing in biofuel and low-carbon energy projects. Technical trends have recently shown neutral to weak momentum.
Technical Analysis and Price Structure
Current Price: $1.6
Support Levels: $1.2β$1.3
Resistance Levels: $1.85β$2.0
Buying Range: $1.5β$2.0
Target Prices
Primary Target: $2.0β$2.2
Secondary Target: $3.0+
$AMTX's recent technical indicators lean neutral/weak, with significant short-term volatility. Fundamentals are heavily influenced by new energy policies and fuel demand.
π Interested? Follow, like, and comment βstocksβ belowβI'll DM you.
#Trading #StockMarket
Calling the buyback βmeaninglessβ ignores how capital allocation actually works for a development-stage company A flexible authorization is standard β committing to fixed repurchases regardless of liquidity, covenants or project timing would be irresponsible not shareholder-friendly
As for βrewarding failure,β most of the items you list are financing or regulatory processes, not binary execution events Large-scale biofuels projects donβt move on retail timelines:
USDA loan guarantees routinely take years from approval to drawdown
EB-5 and CPACE funding are sequential and conditional by design
Export contracts and India-side listings depend on counterparties and regulators, not just management intent
Delays β abandonment. Execution risk is real, but framing every long-dated project as βmissedβ is a simplification, not analysis
If you actually read the 8-K instead of selectively rage-posting, youβd see the buyback authorization, ATM mechanics, and comp disclosures are all standard and fully transparent
Disagree with the thesis all you want, but calling basic filings a βpumpβ isnβt analysis β itβs just emotion